AMGEN ANNOUNCES 2022 THIRD QUARTER DIVIDEND

Go back to AMGEN ANNOUNCES 2022 THIRD QUARTER DIVIDEND

Morgan Stanley on Amgen (AMGN): 'We believe the acquisition will be viewed as a modest positive'

August 4, 2022 10:03 AM EDT

Morgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $253.00 price target on Amgen (NASDAQ: AMGN).

The analyst comments "We believe the acquisition will be viewed as a modest positive given investors are looking for mgt. to expand the pipeline and near-term revenues.... More